Does GEMTUZUMAB OZOGAMICIN Cause Off label use? 88 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 88 reports of Off label use have been filed in association with GEMTUZUMAB OZOGAMICIN (Mylotarg). This represents 4.8% of all adverse event reports for GEMTUZUMAB OZOGAMICIN.
88
Reports of Off label use with GEMTUZUMAB OZOGAMICIN
4.8%
of all GEMTUZUMAB OZOGAMICIN reports
16
Deaths
50
Hospitalizations
How Dangerous Is Off label use From GEMTUZUMAB OZOGAMICIN?
Of the 88 reports, 16 (18.2%) resulted in death, 50 (56.8%) required hospitalization, and 9 (10.2%) were considered life-threatening.
Is Off label use Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for GEMTUZUMAB OZOGAMICIN. However, 88 reports have been filed with the FAERS database.
What Other Side Effects Does GEMTUZUMAB OZOGAMICIN Cause?
Febrile neutropenia (412)
Pyrexia (138)
Sepsis (122)
Thrombocytopenia (117)
Venoocclusive liver disease (117)
Drug ineffective (87)
Death (81)
Bone marrow failure (80)
Neutropenia (68)
Septic shock (59)
What Other Drugs Cause Off label use?
RITUXIMAB (39,751)
INFLIXIMAB (34,801)
DENOSUMAB (34,612)
METHOTREXATE (24,020)
VEDOLIZUMAB (21,017)
ETANERCEPT (20,178)
TOCILIZUMAB (18,256)
PREDNISONE (17,867)
LENALIDOMIDE (17,017)
ADALIMUMAB (16,417)
Which GEMTUZUMAB OZOGAMICIN Alternatives Have Lower Off label use Risk?
GEMTUZUMAB OZOGAMICIN vs GEMZAR
GEMTUZUMAB OZOGAMICIN vs GENTAMICIN
GEMTUZUMAB OZOGAMICIN vs GEODON
GEMTUZUMAB OZOGAMICIN vs GILENYA
GEMTUZUMAB OZOGAMICIN vs GILOTRIF